RNASET2 has been identified as an oncogene with anti-angiogenic and immunomodulatory effects in a variety of cancers, but its function in clear cell renal cell carcinoma (ccRCC) is still not well understood. This evidence concerns the gene RNASET2 and nonpapillary renal cell carcinoma.